The up-regulation of PRDX1 has been observed in bladder cancer, breast cancer, colorectal cancer, lung cancer, gastric cancer, liver cancer, pancreatic cancer, sarcoma, leukemia and lymphoma, while down-regulation was detected in esophageal, head and neck cancers and myeloma [63]. Here, PRDX1 is linked to head and neck cancer.